First Time Loading...

Roche Holding AG
SIX:ROG

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SIX:ROG
Watchlist
Price: 228.75 CHF 0.88%
Updated: Mar 28, 2024

Relative Value

The Relative Value of one ROG stock under the Base Case scenario is 326.5 CHF. Compared to the current market price of 228.75 CHF, Roche Holding AG is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ROG Relative Value
Base Case
326.5 CHF
Undervaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
38
Median 3Y
3.8
Median 5Y
3.8
Industry
2.4
Forward
3
vs History
98
vs Industry
30
Median 3Y
17.5
Median 5Y
18.1
Industry
22.3
Forward
14.4
vs History
65
vs Industry
32
Median 3Y
12.6
Median 5Y
11.7
Industry
16.8
vs History
4
vs Industry
11
Median 3Y
18.3
Median 5Y
17.4
Industry
20.5
vs History
98
vs Industry
11
Median 3Y
7.8
Median 5Y
7.6
Industry
2
vs History
98
vs Industry
35
Median 3Y
4.1
Median 5Y
4
Industry
2.6
Forward
3.2
vs History
98
vs Industry
44
Median 3Y
5.8
Median 5Y
5.6
Industry
5.1
vs History
98
vs Industry
37
Median 3Y
10.4
Median 5Y
10.2
Industry
13.2
Forward
8.6
vs History
98
vs Industry
36
Median 3Y
12.8
Median 5Y
12.3
Industry
16.1
Forward
9.9
vs History
55
vs Industry
31
Median 3Y
13.2
Median 5Y
12.5
Industry
15
vs History
4
vs Industry
13
Median 3Y
18.7
Median 5Y
17.6
Industry
15.8
vs History
98
vs Industry
30
Median 3Y
3.4
Median 5Y
3.5
Industry
2

Multiples Across Competitors

ROG Competitors Multiples
Roche Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Roche Holding AG
SIX:ROG
181.8B CHF 3.1 15.8 8.7 10.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
738.8B USD 21.7 141 63.6 73
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 47 34.3 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
380.2B USD 4.5 10.8 12.1 15.9
US
Merck & Co Inc
NYSE:MRK
333.5B USD 5.5 913.8 45.4 88.6
UK
AstraZeneca PLC
LSE:AZN
166B GBP 4.6 35.2 138.9 222.8
CH
Novartis AG
SIX:NOVN
178.2B CHF 4.2 13.2 9.7 16
US
Pfizer Inc
NYSE:PFE
156.8B USD 2.7 74 11.1 16.6
FR
Sanofi SA
PAR:SAN
114.4B EUR 2.5 21.1 8 11.7
P/E Multiple
Earnings Growth
CH
Roche Holding AG
SIX:ROG
Average P/E: 141.3
15.8
27%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
141
340%
DK
Novo Nordisk A/S
CSE:NOVO B
47
77%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
10.8
-21%
US
Merck & Co Inc
NYSE:MRK
913.8
7 433%
UK
AstraZeneca PLC
LSE:AZN
35.2
172%
CH
Novartis AG
SIX:NOVN
13.2
18%
US
Pfizer Inc
NYSE:PFE
74
679%
FR
Sanofi SA
PAR:SAN
21.1
121%

See Also

Discover More